Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for BioCorRx (BICX) over the last 17 years, with Q2 2025 value amounting to $17.0 million.

  • BioCorRx's Shares Outstanding (Weighted Average) rose 7983.64% to $17.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $17.0 million, marking a year-over-year increase of 7983.64%. This contributed to the annual value of $10.5 million for FY2024, which is 2541.08% up from last year.
  • Per BioCorRx's latest filing, its Shares Outstanding (Weighted Average) stood at $17.0 million for Q2 2025, which was up 7983.64% from $15.1 million recorded in Q1 2025.
  • BioCorRx's 5-year Shares Outstanding (Weighted Average) high stood at $17.0 million for Q2 2025, and its period low was $6.0 million during Q1 2021.
  • Over the past 5 years, BioCorRx's median Shares Outstanding (Weighted Average) value was $8.0 million (recorded in 2023), while the average stood at $8.8 million.
  • As far as peak fluctuations go, BioCorRx's Shares Outstanding (Weighted Average) soared by 616.57% in 2022, and later skyrocketed by 7983.64% in 2025.
  • BioCorRx's Shares Outstanding (Weighted Average) (Quarter) stood at $6.5 million in 2021, then grew by 10.9% to $7.2 million in 2022, then grew by 15.92% to $8.3 million in 2023, then rose by 25.41% to $10.5 million in 2024, then soared by 62.57% to $17.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $17.0 million in Q2 2025, compared to $15.1 million in Q1 2025 and $10.5 million in Q4 2024.